HARVARD BIOSCIENCE INC (HBIO)

↓ Download CSV

CIK 0001123494 · Nasdaq · Laboratory Analytical Instruments

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

In fiscal 2025, HARVARD BIOSCIENCE INC reported revenue of $86.55M, down 8.1% from the prior year. The company ran a net loss, with a net margin of -65.5% and a gross margin of 57.7%. It held $80.07M in total assets against $66.34M in total liabilities.

Key ratios (FY2025)

57.7%
Gross margin
-56.1%
Operating margin
-65.5%
Net margin
-412.8%
Return on equity
-8.1%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$86.55M$94.14M$112.25M$113.33M$118.90M$102.10M$116.18M$120.77M
Cost of Revenue$36.64M$39.37M$46.18M$52.52M$51.25M$44.06M$51.85M$57.59M$38.24M$56.11M
Gross Profit$49.91M$54.77M$66.07M$60.82M$67.65M$58.04M$64.32M$63.18M$39.17M$48.41M
Operating Income-$48.58M-$6.21M$1.89M-$6.93M$2.07M$221.0K$377.0K$984.0K-$635.0K-$3.00M
Net Income-$56.70M-$12.40M-$3.42M-$9.52M-$288.0K-$7.81M-$4.69M-$2.92M-$865.0K-$4.31M
EPS (Diluted)$-1.28$-0.28$-0.08$-0.23$-0.01$-0.12$-0.08$-0.02$-0.13
Total Assets$80.07M$126.64M$137.37M$145.36M$162.34M$156.25M$164.87M$168.61M$109.35M$107.77M
Total Liabilities$66.34M$63.30M$64.29M$73.14M$78.94M$79.57M$83.18M$85.89M$28.45M$35.57M
Shareholders' Equity$13.73M$63.34M$73.07M$72.22M$83.40M$76.68M$81.69M$82.72M$80.90M$72.20M
Cash & Equivalents$8.61M$4.11M$4.28M$4.51M$7.82M$8.32M$8.34M$8.17M$5.19M$5.60M
Operating Cash Flow$6.73M$1.44M$14.03M$1.15M$1.26M$9.33M$8.04M$2.88M$1.06M$5.38M
Capital Expenditures$1.26M$2.64M$1.79M$1.59M$1.20M$1.15M$1.22M$986.0K$890.0K
Shares Outstanding44.39M43.54M42.42M41.41M40.34M38.64M37.81M36.45M34.75M34.21M